Affiliation:
1. Department of Infection, Immunity and Inflammation, Institute for Lung Health, Glenfield Hospital, University of Leicester, LE3 9QP, U.K.
Abstract
The pathogenesis of asthma is complex and multi-faceted. Asthma patients have a diverse range of underlying dominant disease processes and pathways despite apparent similarities in clinical expression. Here, we present the current understanding of asthma pathogenesis. We discuss airway inflammation (both T2HIGH and T2LOW), airway hyperresponsiveness (AHR) and airways remodelling as four key factors in asthma pathogenesis, and also outline other contributory factors such as genetics and co-morbidities. Response to current asthma therapies also varies greatly, which is probably related to the inter-patient differences in pathogenesis. Here, we also summarize how our developing understanding of detailed pathological processes potentially translates into the targeted treatment options we require for optimal asthma management in the future.
Reference92 articles.
1. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma;Bousquet;J. Allergy. Clin. Immunol.,2010
2. Global strategy for asthma management and prevention;Global Initiative for Asthma (GINA),2016
3. British guideline on the management of asthma;British Thoracic Society/Scottish Intercollegiate Guidelines Network,2016
4. National Asthma Education and Prevention Program, Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma;National Heart, Lung, and Blood Institute,2007
5. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur. Respir. J.,2014
Cited by
123 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献